2011 Annual Meeting

The following presentations were given during the 2011 NABP Annual Meeting, May 21-24, 2011 in San Antonio, TX.

International Pharmacy Practice – Bridging the Globe

This special pre-meeting continuing pharmacy education (CPE) session will focus on international pharmacy practice and how other countries regulate the practice of pharmacy. Attendees will learn how various countries allow for use of technology, therapeutic management, pharmacist intervention, and prescriptive authority. Presenters will provide their countries’ regulatory schemes, practice standards, and model rules with an emphasis on new practices regarding medication therapy management, collaborative practice, pharmacy ownership, and mail order.

Learning Objectives:

At the conclusion of this session, participants will be able to:

  1. Describe the regulatory frameworks for the practice of pharmacy in Australia and various European countries.
  2. Explain how the practice standards for pharmacy in Australia and various European countries differ from those in the United States.
  3. Describe how collaborative practice is utilized in Australia and various European countries.

Legal and Government Affairs Update – San Antonio Confidential

Participants will learn about the current laws regarding the protection of confidential information that might be required or accessed by boards of pharmacy and what information can be required in order to validate identities. Information on the limits and protections of the Americans with Disabilities Act in regard to examinations and test site accommodations as well as states’ efforts to develop and operate prescription monitoring programs will also be presented.

Learning Objectives:

At the conclusion of this session, participants will be able to:

  1. Explain how the protection of confidential information may affect how boards of pharmacy can utilize this information in order to validate identities.
  2. Describe the limits and protections of the Americans with Disabilities Act in regard to examinations and test site accommodations for licensure candidates.

NABP/USP Breakfast

The NABP/USP Breakfast, sponsored by the United States Pharmacopeial Convention (USP), is an opportunity for both organizations to discuss timely and relevant topics in the pharmacy profession. USP representatives discuss newly proposed and released USP quality standards of relevance to the boards of pharmacy.

  • Shawn Becker, MS, RN, Director, Healthcare Quality Standards, United States Pharmacopeial Convention
  • Rick Schnatz, PharmD, Scientific Liaison, Compounding Expert Committee, United States Pharmacopeial Convention
    Joint Presentation: 2011 NABP-USP Breakfast (PDF)

Social Media – To Tweet or Not to Tweet?

Should you believe everything you hear? What should and/or can state boards of pharmacy place on Facebook, Twitter, and the like for sharing and obtaining information? What are the legal implications that boards of pharmacy face? How should boards deal with these changing audiences and resources? A regulatory expert will provide attendees with information regarding today’s technology of friending and tweeting.

Learning Objectives:

At the conclusion of this session, participants will be able to:

  1. Describe possible legal implications that the boards of pharmacy face when publishing information on Facebook or Twitter.
  2. Explain how boards of pharmacy can utilize social media technology legally and safely.

FDA Update – A Guide for APIs and INDs

What do you need to know about APIs and investigative new drugs (INDs)? Food and Drug Administration (FDA) representatives will provide compliance officers with information on how to deal with APIs and INDs while conducting compounding pharmacy inspections.

  • Edisa Gozun, PharmD, Consumer Safety Officer, Division of New Drugs and Labeling Compliance, Office of Compliance, Center for Drug Evaluation and Research, Food and Drug Administration
  • Samia M. Nasr, RPh, MS, Team Leader, Compounding Team, Division of New Drugs and Labeling Compliance, Office of Compliance, Center for Drug Evaluation and Research, Food and Drug Administration
    Joint Presentation: Current Topics in Pharmacy Compounding (PDF)

Learning Objectives:

At the conclusion of this session, participants will be able to:

  1. Describe how an inspector should manage active pharmaceutical ingredients (APIs) while conducting a compounding pharmacy inspection.
  2. Explain how a pharmacy can legally compound investigative new drugs (IND).

Rogue Internet Pharmacies – Can Collaboration Break the Link?

As we know the world of rogue Internet pharmacies is a very dangerous place. Statistics show that abuse of prescription medication has become an epidemic, particularly due to the ease that drugs can be obtained over the Internet. Patients are also exposed to dangerous counterfeit and unapproved medications. Participants will learn what the Association, government, and the industry are now doing to combat this danger and advance patient safety.

Learning Objectives:

At the conclusion of this session, participants will be able to:

  1. Explain how rogue Internet pharmacies have impacted the abuse of prescription medication in the US.
  2. Describe efforts by NABP, the government, and the industry to combat rogue Internet pharmacies and advance patient safety.
RSS

Recent News

More Newsroom Headlines »